PubRank

Fabio Malavasi

Author PubWeight™ 81.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. J Hepatol 2006 2.74
2 CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. Blood 2003 1.99
3 CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. Blood 2004 1.63
4 TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway. J Cell Sci 2006 1.55
5 In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia. Blood 2006 1.49
6 CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential. Blood 2007 1.35
7 Two genetic variants of CD38 in subjects with autism spectrum disorder and controls. Neurosci Res 2010 1.35
8 CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. Cancer Res 2009 1.34
9 CD molecules 2005: human cell differentiation molecules. Blood 2005 1.27
10 CD molecules 2006--human cell differentiation molecules. J Immunol Methods 2006 1.23
11 The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia. Haematologica 2013 1.21
12 CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells. Blood 2005 1.20
13 Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network. Cancer Res 2011 1.13
14 CD38 is expressed on human mature monocyte-derived dendritic cells and is functionally involved in CD83 expression and IL-12 induction. Eur J Immunol 2004 1.11
15 CD38/CD19: a lipid raft-dependent signaling complex in human B cells. Blood 2007 1.11
16 CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death. Blood 2011 1.09
17 A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes. Oncoimmunology 2013 1.07
18 Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects. Breast Cancer Res Treat 2002 1.07
19 Exosomes from human lymphoblastoid B cells express enzymatically active CD38 that is associated with signaling complexes containing CD81, Hsc-70 and Lyn. Exp Cell Res 2010 1.06
20 CD38 signaling in T cells is initiated within a subset of membrane rafts containing Lck and the CD3-zeta subunit of the T cell antigen receptor. J Biol Chem 2003 1.05
21 CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt/protein kinase B and Erk activation in the absence of the CD3-zeta immune receptor tyrosine-based activation motifs. J Biol Chem 2001 1.03
22 IFN-gamma arms human dendritic cells to perform multiple effector functions. J Immunol 2008 1.03
23 Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells. Cell Res 2011 1.02
24 CD38 and CD157: a long journey from activation markers to multifunctional molecules. Cytometry B Clin Cytom 2013 1.01
25 Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia. Blood 2002 1.00
26 Transferrin receptor 2 is frequently expressed in human cancer cell lines. Blood Cells Mol Dis 2007 0.98
27 Chronic lymphocytic leukemia microenvironment: shifting the balance from apoptosis to proliferation. Haematologica 2009 0.97
28 CD38 at the junction between prognostic marker and therapeutic target. Trends Mol Med 2008 0.96
29 CD157, the Janus of CD38 but with a unique personality. Cell Biochem Funct 2002 0.96
30 Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule. Mol Med 2013 0.95
31 Antigen-induced clustering of surface CD38 and recruitment of intracellular CD38 to the immunologic synapse. Blood 2008 0.95
32 Chemotaxis of human tonsil B lymphocytes to CC chemokine receptor (CCR) 1, CCR2 and CCR4 ligands is restricted to non-germinal center cells. Int Immunol 2002 0.95
33 CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome? Blood 2008 0.94
34 CD157 is an important mediator of neutrophil adhesion and migration. Blood 2004 0.94
35 CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells. Mol Med 2009 0.93
36 All-trans retinoic acid upregulates reduced CD38 transcription in lymphoblastoid cell lines from Autism spectrum disorder. Mol Med 2011 0.93
37 A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine. FEMS Immunol Med Microbiol 2011 0.92
38 CD157 plays a pivotal role in neutrophil transendothelial migration. Blood 2006 0.91
39 Role of CD31/platelet endothelial cell adhesion molecule-1 expression in in vitro and in vivo growth and differentiation of human breast cancer cells. Am J Pathol 2003 0.91
40 Mechanism-based small molecule probes for labeling CD38 on live cells. J Am Chem Soc 2009 0.90
41 Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells. Blood 2002 0.89
42 Use of genetic immunization to raise antibodies recognizing toxin-related cell surface ADP-ribosyltransferases in native conformation. Cell Immunol 2005 0.89
43 Retinoic acid-induced CD38 antigen as a target for immunotoxin-mediated killing of leukemia cells. Mol Cancer Ther 2004 0.89
44 ATRA-induced HL-60 myeloid leukemia cell differentiation depends on the CD38 cytosolic tail needed for membrane localization, but CD38 enzymatic activity is unnecessary. Exp Cell Res 2010 0.87
45 Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum. Blood 2002 0.87
46 The role of platelet/endothelial cell adhesion molecule 1 (CD31) and CD38 antigens in marrow microenvironmental retention of acute myelogenous leukemia cells. Cancer Res 2007 0.87
47 Flow cytometric and immunoblot assays for cell surface ADP-ribosylation using a monoclonal antibody specific for ethenoadenosine. Anal Biochem 2003 0.86
48 Are retinoids potential therapeutic agents in disorders of social cognition including autism? FEBS Lett 2011 0.86
49 Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp120. FASEB J 2003 0.85
50 CD38 ligation plays a direct role in the induction of IL-1beta, IL-6, and IL-10 secretion in resting human monocytes. Cell Immunol 2002 0.85
51 HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism. Haematologica 2013 0.85
52 Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche. Ann N Y Acad Sci 2014 0.84
53 Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia. Am J Hematol 2007 0.84
54 Stable coordination of the inhibitory Ca2+ ion at the metal ion-dependent adhesion site in integrin CD11b/CD18 by an antibody-derived ligand aspartate: implications for integrin regulation and structure-based drug design. J Immunol 2011 0.83
55 Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C. J Gastroenterol Hepatol 2006 0.83
56 Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells. BMC Biotechnol 2008 0.82
57 CD38 as a molecular compass guiding topographical decisions of chronic lymphocytic leukemia cells. Semin Cancer Biol 2010 0.82
58 Ectoenzymes and innate immunity: the role of human CD157 in leukocyte trafficking. Front Biosci (Landmark Ed) 2009 0.81
59 Functional, structural, and distribution analysis of the chorionic gonadotropin receptor using murine monoclonal antibodies. J Clin Endocrinol Metab 2003 0.81
60 Purification of clinical-grade monoclonal antibodies by chromatographic methods. Methods Mol Biol 2005 0.81
61 A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome. Br J Haematol 2010 0.80
62 A panel of monoclonal antibodies recognizing GPI-anchored ADP-ribosyltransferase ART4, the carrier of the Dombrock blood group antigens. Cell Immunol 2005 0.80
63 Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options. Cancer Lett 2012 0.80
64 Expression of P2X7 ATP receptor mediating the IL8 and CCL20 release in human periodontal ligament stem cells. J Cell Biochem 2014 0.80
65 Transferrin receptor 2 is frequently and highly expressed in glioblastomas. Transl Oncol 2010 0.80
66 Editorial: CD38 and retinoids: a step toward a cure. J Leukoc Biol 2011 0.79
67 Transferrin receptor 2 protein is not expressed in normal erythroid cells. Biochem J 2004 0.79
68 CD38 is a marker of human lacteals. Virchows Arch 2002 0.79
69 Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients. Cytokine 2013 0.79
70 TfR2 expression in human colon carcinomas. Blood Cells Mol Dis 2009 0.79
71 Contribution of dendritic cells' FcgammaRI and FcgammaRIII to cross-presentation of tumor cells opsonized with the anti-MHC class I monoclonal antibodies. Cancer Biol Ther 2007 0.79
72 The CD38/CD157 mammalian gene family: An evolutionary paradigm for other leukocyte surface enzymes. Purinergic Signal 2006 0.78
73 Radioimmunotherapy in advanced ovarian cancer: is there a role for pre-targeting with (90)Y-biotin? Gynecol Oncol 2004 0.78
74 Design and scaleup of downstream processing of monoclonal antibodies for cancer therapy: from research to clinical proof of principle. J Immunol Methods 2003 0.78
75 Binding of prostate-specific membrane antigen to dendritic cells: a critical step in vaccine preparation. Cytotherapy 2009 0.77
76 CD38 and CD157 ectoenzymes mark cell subsets in the human corneal limbus. Mol Med 2008 0.77
77 Different aquaporin-4 expression in glioblastoma multiforme patients with and without seizures. Mol Med 2012 0.77
78 NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model. FEBS Lett 2011 0.77
79 Simultaneous expression of CD38 and its ligand CD31 by chronic lymphocytic leukemia B-cells: anecdotal observation or pathogenetic hypothesis for the clinical outcome? Haematologica 2003 0.77
80 Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil. Haematologica 2002 0.77
81 Death of T cell precursors in the human thymus: a role for CD38. Int Immunol 2003 0.76
82 CD38 and behavior: moving from correlation to causality? Biol Psychiatry 2012 0.76
83 Immunodetection of anti-MAG IgM antibody by cross-reactivity to LA-N-1 neuroblastoma cells. J Neuroimmunol 2005 0.76
84 Characterization and phylogenetic epitope mapping of CD38 ADPR cyclase in the cynomolgus macaque. BMC Immunol 2004 0.76
85 Regulation of transferrin receptor 2 in human cancer cell lines. Blood Cells Mol Dis 2008 0.75